Search filters

List of works by Sridharan Gururangan

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

scientific article published on 28 February 2017

A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma

scientific article

Advances in the diagnosis and treatment of malignant childhood brain tumors

scientific article published in February 2007

Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma

scientific article published on August 2008

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

scientific article published on 19 September 2013

Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation

scientific article

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas

scientific article published on November 2008

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

scientific article published in October 2007

Bevacizumab-Associated Osteonecrosis of the Wrist and Knee in Three Pediatric Patients With Recurrent CNS Tumors ⬇️

scientific article published on November 19, 2012

CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity

scientific article

Chemotherapy and novel therapeutic approaches in malignant glioma

scientific article

DIPG-23. PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY (X-ALT) PLUS TOTAL TUMOR RNA-DENDRITIC CELL VACCINE (TTRNA-DC) + HEMATOPOIETIC STEM CELLS (HSC) DURING RECOVERY FROM IRRADIATION(RT) WITH (GROUP A) OR WITHOUT (GROUP B) DOSE-INTENSIFIED TEMOZOLOMID

scientific article

DIPG-29. GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT.

scientific article published on 31 May 2017

EPT-06OUTCOMES FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA OR EPENDYMOMA ENROLLED ON PHASE II CLINICAL TRIALS: AN ANALYSIS OF CONTEMPORARY CHILDREN'S ONCOLOGY GROUP (COG) AND PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) TRIALS.

scientific article published on 30 May 2016

EPT-19PHASE I TRIAL OF PALBOCICLIB, A CDK4/6 INHIBITOR IN CHILDREN WITH RETINOBLASTOMA PROTEIN (RB1) + RECURRENT CENTRAL NERVOUS SYSTEM (CNS) TUMORS (PBTC 042).

scientific article published on 30 May 2016

Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma

scientific article

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study

scientific article published on 04 December 2013

Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma

scientific article published on 28 August 2008

Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma

scientific article

Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma

scientific article published on 27 August 2015

Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium

scientific article

Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations

scientific article published on 4 May 2015

HG-41OUTCOMES FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA ENROLLED ON PHASE II CLINICAL TRIALS: AN ANALYSIS OF CONTEMPORARY CHILDREN'S ONCOLOGY GROUP (COG) AND PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) TRIALS.

scientific article published on 30 May 2016

High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor

scientific article published on 31 May 2007

High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas

scientific article published in June 2003

Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma.

scientific article

IMMU-11. AN ANALYSIS OF IMMUNOPHENOTYPE, INCLUDING PD-L1 AND PD1 EXPRESSION, IN PEDIATRIC CNS MALIGNANCIES: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY.

scientific article published on 31 May 2017

Identification of distinct and overlapping cortical areas for bilingual naming and reading using cortical stimulation. Case report

scientific article published on March 2008

Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma

scientific article published in April 2006

Initial testing of VNP40101M (Cloretazine) by the pediatric preclinical testing program

scientific article

Innovations in design and delivery of chemotherapy for brain tumors

scientific article

Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration

scientific article published on 10 November 2016

Intracranial Ewing sarcoma

scientific article

Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study

scientific article

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

scientific article

Late effects of chemotherapy

scientific article published on January 2009

MB-94IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11).

scientific article published on 30 May 2016

Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation

scientific article

Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents

scientific article published on April 2010

Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results

scientific article

Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma

scientific article

Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma

scientific article published on April 2004

Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma

scientific article

Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

scientific article

Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma

scientific article published on April 2004

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

scientific article

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma

scientific article published on May 2009

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma

scientific article

Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study

scientific article

Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study

scientific article published on February 2008

Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).

scientific article published on March 2006

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma

scientific article published in October 2005

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report

scientific article

Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma

scientific article

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

scientific article

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study

scientific article

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma

scientific article

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

scientific article published on 22 September 2011

Phase II study of carboplatin in children with progressive low-grade gliomas

scientific article

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma

scientific article

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

scientific article

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

scientific article

Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience

scientific article published in April 2002

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

scientific article

Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme

scientific article published on February 2009

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

scientific article

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

scientific article published in February 2007

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

scientific article published on May 2002

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

scientific article published in January 2005

Phase II trial of temozolomide in patients with progressive low-grade glioma

scientific article

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

scientific article

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

scientific article published on 11 March 2016

Pulmonary Function After Treatment for Embryonal Brain Tumors on SJMB03 That Included Craniospinal Irradiation

scientific article published on 19 May 2015

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

scientific article published on 17 October 2013

Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).

scientific article

Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma

scientific article published on 21 March 2008

Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

scientific article published in January 2006

Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer

scientific article published in December 2004

Sluggish cognitive tempo in survivors of pediatric brain tumors ⬇️

scientific article published on May 10, 2013

Social functioning and facial expression recognition in survivors of pediatric brain tumors

scientific article published on 5 April 2008

Temozolomide in children with progressive low-grade glioma

scientific article

The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial

scientific article published on 18 November 2016

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

scientific article published on 06 June 2016

Transformation of juvenile pilocytic astrocytoma to anaplastic pilocytic astrocytoma in patients with neurofibromatosis type I.

scientific article published in July 2011

Trilateral retinoblastoma: clinical and radiologic progression

scientific article

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

scientific article

[18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma

scientific article published in December 2004

Paulina is supported by:

About Paulina

Help